Development and use of palivizumab (Synagis) : a passive immunoprophylactic agent for RSV

• POLLACK Paul

  Global Research and Development, Abbott Laboratories

• GROOTHUIS Jessie R.

  Global Research and Development, Abbott Laboratories

収録刊行物

• Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 8 (3), 201-206, 2002-09-01

キーワード

• Respiratory syncytial virus (RSV)
• Bronchiolitis
• Chronic lung disease (CLD)
• Bronchopulmonary dysplasia (BPD)
• Prematurity
• Humanized monoclonal antibody
• Palivizumab (Synagis)
• IMpact-RSV study

詳細情報

• CRID: 1574231875584086016
• NII論文ID: 50000646293
• NII書誌ID: AA11057978
• ISSN: 1341321X
• Web Site: https://search.jamas.or.jp/link/ui/2003074792
• 本文言語コード: en
• データソース種別:
  • CiNii Articles